4-benzyl-3-crotonyl-2-oxazolidinone has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beshir, AB; Fenteany, G; Mc Henry, KT; Montesano, R; Tang, HH; Yeung, KC; Zhu, S | 1 |
1 other study(ies) available for 4-benzyl-3-crotonyl-2-oxazolidinone and Breast Cancer
Article | Year |
---|---|
Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion.
Topics: Adherens Junctions; Animals; Breast Neoplasms; Cadherins; Cell Movement; Cell-Matrix Junctions; Dogs; Down-Regulation; Epithelial Cells; Extracellular Matrix; Extracellular Matrix Proteins; Humans; Integrin beta1; Kidney Neoplasms; Membrane Proteins; Oxazolidinones; Phosphatidylethanolamine Binding Protein; Phosphoproteins; Protein Kinase Inhibitors; raf Kinases; RNA Interference; Tumor Cells, Cultured; Up-Regulation; Wound Healing; Zonula Occludens-1 Protein | 2008 |